Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Schibsted in conjunction with sale of shares in Hitta.se
Mandate

Vinge advises Schibsted in conjunction with sale of shares in Hitta.se

July 18, 2017

Vinge has advised Schibsted in conjunction with the sale of 90.2 per cent of the shares in Hitta.se.

The buyers are Alexander Hannerland and Stefan Tocca, both with a background in Hitta.se and Schibsted respectively, as well as Sprints Capital Management, a London based investment company founded by Henrik Persson. Last year, Hitta.se’s turnover was MSEK 257 with an EBITDA of MSEK 69.

Vinge’s team consisted of partners Johan Winnerblad and Kristina Ekberg together with associates Louise Nordkvist and Jonas Borg.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025